Aso, T., Matsuo, M., Kiyohara, H., Taguchi, K., Rikimaru, F., Shimokawa, M., . . . Masuda, M. (2015). Induction of CD44 Variant 9-Expressing Cancer Stem Cells Might Attenuate the Efficacy of Chemoradioselection and Worsens the Prognosis of Patients with Advanced Head and Neck Cancer. PLoS One.
استشهاد بنمط شيكاغوAso, Takeichiro, et al. "Induction of CD44 Variant 9-Expressing Cancer Stem Cells Might Attenuate the Efficacy of Chemoradioselection and Worsens the Prognosis of Patients With Advanced Head and Neck Cancer." PLoS One 2015.
MLA استشهادAso, Takeichiro, et al. "Induction of CD44 Variant 9-Expressing Cancer Stem Cells Might Attenuate the Efficacy of Chemoradioselection and Worsens the Prognosis of Patients With Advanced Head and Neck Cancer." PLoS One 2015.